Autopsy report · NCT06120504
A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers
Cause of deathFunding or business
“Study terminated as part of strategic considerations”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 9 months before it stopped.
- 22 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Sponsor type
- Industry
- Conditions
- Lymphoma, T-Cell, Cutaneous; Hodgkin Disease; Lymphoma, T-Cell, Peripheral; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
- Interventions
- PF-08046045
- Participants
- 22
- Sites
- 16
- Countries
- Spain, United States
Trials that died the same way
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
“Study terminated for strategic business reasons” - A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
“The study was terminated due to strategic business reasons.” - Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6
“Study terminated due to business and strategic decision.” - GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
“The study was terminated from a business perspective.” - An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
“Study was prematurely terminated due to administrative and strategic reasons”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.